Brown Advisory Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,716
Closed -$350K 406
2017
Q3
$350K Sell
1,716
-102
-6% -$23.7K 0.08% 235
2017
Q2
$442K Buy
1,818
+84
+5% +$19.7K 0.1% 203
2017
Q1
$417K Sell
1,734
-974
-36% -$227K 0.1% 199
2016
Q4
$569K Buy
2,708
+373
+16% +$77.3K 0.16% 152
2016
Q3
$539K Buy
2,335
+550
+31% +$134K 0.16% 160
2016
Q2
$410K Buy
+1,785
New +$412K 0.13% 174

Other funds holding AGN

Brown Advisory Securities's AGN Position: Q4 2017 in Review

Brown Advisory Securities sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 1,716 shares — an estimated $350K sold.

Brown Advisory Securities first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $569K in Q4 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Brown Advisory Securities reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Brown Advisory Securities sold 1,716 Allergan plc shares in Q4 2017, an estimated $350K.
  • Brown Advisory Securities first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Brown Advisory Securities's Allergan plc position peaked at $569K in Q4 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Brown Advisory Securities's 13F filing for Q4 2017, filed 12 Feb 2018.